Life Sciences

BIOVECTRA enhances manufacturing capacity with ABEC microbial fermentation technology

By In partnership with

ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, is to design, manufacture, and install CSR single-use microbial fermentation solutions at BIOVECTRA’s manufacturing facility in Windsor, Nova Scotia, Canada to enhance BIOVECTRA’s high-growth microbial fermentation processes and provide fast turnaround product to product and between batches. The ABEC fast-track manufacturing schedule will enable BIOVECTRA to be fully operational by Q2, 2022.

ABEC is also supplying to BIOVECTRA CSR single-use disposable containers (DCs) from its two in-house ISO-7 cleanroom manufacturing facilities in Bethlehem, Pennsylvania. and Fermoy, Ireland. BIOVECTRA stated that these facilities, in addition to ABEC’s qualification of multiple single-use instrument and component suppliers, would ensure a robust supply chain and timely delivery to meet its rapid time-to-market needs.